Catalogo dei prodotti della ricerca

BARATTA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.078
EU - Europa 971
AS - Asia 359
AF - Africa 17
SA - Sud America 15
OC - Oceania 7
Totale 4.447
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.048
IT - Italia 527
IN - India 143
CN - Cina 118
SE - Svezia 95
BG - Bulgaria 70
DE - Germania 53
SG - Singapore 48
FI - Finlandia 46
IE - Irlanda 39
FR - Francia 28
CA - Canada 27
GB - Regno Unito 27
JO - Giordania 24
RO - Romania 19
UA - Ucraina 15
NL - Olanda 14
TR - Turchia 14
AR - Argentina 13
TG - Togo 12
AT - Austria 11
AU - Australia 7
CH - Svizzera 6
HK - Hong Kong 6
PL - Polonia 5
TN - Tunisia 5
BE - Belgio 3
ES - Italia 3
GR - Grecia 3
NO - Norvegia 3
MX - Messico 2
PH - Filippine 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
IR - Iran 1
JM - Giamaica 1
MK - Macedonia 1
MY - Malesia 1
SA - Arabia Saudita 1
Totale 4.447
Salva come PNG Salva come JPEG
Città #
Fairfield 538
Woodbridge 235
Ashburn 228
Rome 214
Seattle 212
Houston 199
Chandler 186
Cambridge 183
Wilmington 168
Ann Arbor 129
Dearborn 102
Princeton 88
San Paolo di Civitate 80
Sofia 70
Beijing 61
Millbury 57
Fremont 56
Lawrence 56
Plano 42
Dublin 39
New York 37
San Diego 27
Andover 23
Bremen 21
Amman 19
Boston 18
Norwalk 17
Helsinki 15
Singapore 14
Phoenix 13
Lomé 12
Ottawa 12
Samsun 10
Toronto 10
Glendale 9
Rochester 8
Vienna 8
Falls Church 7
Federal 7
Hyderabad 7
Redwood City 7
Amsterdam 6
Geneva 6
Hong Kong 6
Nanjing 6
San Severo 6
Southend 6
Bari 5
Buenos Aires 5
Fuzhou 5
Kunming 5
Megrine 5
Monterotondo 5
Sacramento 5
Velletri 5
Zarqa 5
Arezzo 4
Asti 4
Bermondsey 4
Cagliari 4
Des Moines 4
Hefei 4
London 4
Los Angeles 4
Marseille 4
Menlo Park 4
Mesa 4
Milan 4
Paris 4
Pescara 4
Sabaudia 4
Salerno 4
Surat 4
Boardman 3
Bovezzo 3
Bromley 3
Brussels 3
Catania 3
Grafing 3
Groningen 3
Izmir 3
Jacksonville 3
Napoli 3
San Mateo 3
Seregno 3
Surprise 3
Aubusson 2
Berlin 2
Bitonto 2
Buffalo 2
Bulgarograsso 2
Bühl 2
Chengdu 2
Chongqing 2
Dallas 2
Duncan 2
Flagstaff 2
Frankfurt am Main 2
Genazzano 2
Genoa 2
Totale 3.460
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 162
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation. the ARAPACIS study 142
Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis 141
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 108
Adherence to mediterranean diet and non-alcoholic fatty liver disease. effect on insulin resistance 104
Under-prescription of statins in patients with non-alcoholic fatty liver disease 99
Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy 99
Off-label use of ceftaroline fosamil: a systematic review 98
PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress 95
Similar reduction of cholesterol-adjusted Vitamin E serum levels in simple steatosis and non-alcoholic steatohepatitis 91
Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome 90
Overexpression of the vitronectin v10 subunit in patients with nonalcoholic steatohepatitis: Implications for noninvasive diagnosis of NASH 88
Severity of OSAS, CPAP and cardiovascular events: a follow-up study 86
Non-alcoholic fatty liver disease and subclinical atherosclerosis: a comparison of metabolically- versus genetically-driven excess fat hepatic storage 85
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study 84
Progressive reduction of blood lysosomal acid lipase activity according to stage of adult chronic liver disease and altered enzymatic cellular distribution in cirrhosis 81
Relation of Nonalcoholic Fatty Liver Disease and Framingham Risk Score to Flow-Mediated Dilation in Patients With Cardiometabolic Risk Factors 80
Oxidative stress: new insights on the association of nonalcoholic fatty liver disease and atherosclerosis 80
Effects of dark chocolate on endothelial function in patients with non-alcoholic steatohepatitis 78
Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study 78
P848 SERUM CYTOKERATIN-18 IS ASSOCIATED WITH OXIDATIVE STRESS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 73
Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants 73
Reduced lysosomal acid lipase activity in adult patients with non-alcoholic fatty liver disease 72
Reduced lysosomal acid lipase activity in blood and platelets is associated with nonalcoholic fatty liver disease 71
Obesity and Hypercholesterolemia are Associated with NOX2 Generated Oxidative Stress and Arterial Dysfunction 69
Twelve variants polygenic score for low-density lipoprotein cholesterol distribution in a large cohort of patients with clinically diagnosed familial hypercholesterolemia with or without causative mutations 68
Statins and non-alcoholic fatty liver disease 68
Incidence of post-implantation syndrome with different endovascular aortic aneurysm repair modalities and devices and related etiopathogenetic implications 68
Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease 67
Non-alcoholic fatty liver disease and cardiovascular disease: Epidemiological, clinical and pathophysiological evidences 67
Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease? 66
Post-Implantation Syndrome. The impact of different devices for endovascular abdominal aortic aneurysm repair and related etiopathogenetic implications 65
Current Ways of Treating Dyslipidemias to Prevent Atherosclerosis 63
The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease 63
Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease 63
The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease 63
Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose 62
Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment 61
Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation 61
Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver 59
Increased liver localization of lipopolysaccharides in human and experimental NAFLD 59
Moderate weight loss decreases oxidative stress and increases antioxidant status in patients with metabolic syndrome 57
Added fructose in non-alcoholic fatty liver disease and in metabolic sindrome. a narrative review 56
HDL-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease (NAFLD) 55
Poor adherence to mediterranean diet and serum lipopolysaccharide are associated with oxidative stress in patients with non-alcoholic fatty liver disease 54
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease 53
Obstructive Sleep Apnea and the Metabolic Syndrome: Pathophysiological and Clinical Evidence 51
The post-implantation syndrome(PIS). The impact of different devices for endovascular abdominal aortic aneurysm repair (EVAR) and related etiopathogenetic implications 51
Sex-related differences in the association between metabolic syndrome and gallstone disease 51
Assessment of hepatic fibrosis in MAFLD..a new player in the evaluation of residual cardiovascular risk 51
Modern approach to the clinical management of non-alcoholic fatty liver disease 49
P825 NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH REDUCED SERUM CHOLESTEROL-ADJUSTED VITAMIN E LEVELS 48
New insights into the pathogenesis of non-alcoholic fatty liver disease: gut-derived lipopolysaccharides and oxidative stress 48
High cardiovascular risk in non-alcoholic fatty liver disease: a possible role for increased oxidative stress. 47
Correction to: Reduced lysosomal acid lipase activity in blood and platelets Is associated with nonalcoholic fatty liver disease 47
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis 46
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? 45
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. a prospective multicenter cohort study 42
The challenge of cardiovascular prevention in NAFLD 41
Statin use and mortality in atrial fibrillation. A systematic review and meta-analysis of 100,287 patients 40
NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease 39
Ridotta attività della lipasi acida lisosomiale: un possibile ruolo patogenetico nella nafld? 38
The intricacies of the Mediterranean diet in NAFLD. Response to Duret et al 38
Predictors of weight loss in patients with obesity treated with a Very Low-Calorie Ketogenic Diet 37
Endotelial dysfunction and increased oxidative stress in patients with obstructive sleep dyspnea. Effect of CPAP therapy. 34
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis 32
Extra virgin olive oil reduces gut permeability and metabolic endotoxemia in diabetic patients 31
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways 31
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study 30
Sindrome delle apnee ostruttive del sonno e rischio cardiovascolare 29
Nonalcoholic fatty liver disease and the kidney: a review 29
null 27
PNPLA3 I148M gene variant is not associated with metabolic syndrome and cardiometabolic risk in non-alcoholic fatty liver disease 26
Is the mediterranean diet the best approach to NAFLD treatment today 24
High compliance to mediterranean diet associates with lower platelet activation and liver collagen deposition in patients with nonalcoholic fatty liver disease 24
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): implication for cardiovascular risk stratification 19
Prevention and management of type ii diabetes chronic complications. the role of polyphenols (mini-review) 19
Commentary on "effect of green-mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial" 19
null 17
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease 17
Oxidative stress mediated platelet activation in patients with congenital analbuminemia. Effect of albumin infusion 10
Open issues in the transition from nafld to mafld. the experience of the plinio study 5
Totale 4.857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019287 0 0 0 0 0 0 0 0 0 55 119 113
2019/20201.084 91 27 37 31 101 174 208 121 118 71 71 34
2020/2021704 50 29 20 61 15 73 10 20 63 220 115 28
2021/2022908 22 30 78 49 104 56 17 64 61 67 200 160
2022/2023939 168 201 52 62 72 84 21 119 57 14 59 30
2023/2024536 45 68 29 47 71 138 33 35 10 60 0 0
Totale 4.857